FDA Approved: AUSTEDO — Supplemental Application (Teva Neuroscience, Inc.)

View source ↗

Summary

The FDA approved Teva's supplemental application for Austedo (deutetrabenazine) to update the product labeling. This likely reflects changes to indications, dos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease
• Tardive Dyskinesia

Drugs mentioned

• AUSTEDO (deutetrabenazine)

Snippet

SUPPL AP for AUSTEDO (DEUTETRABENAZINE)